Veralox Therapeutics

Frederick, MD · Founded 2017 · Privately Held (backing)

Developer of small molecule therapeutics designed to target heparin-induced thrombocytopenia and thrombosis. Veralox Therapeutics is based in Frederick, MD and was founded in 2017. It was valued at $66 million at its later-stage round in Jun 2023, the last priced event on record. It has raised $41.2 million across 3 recorded rounds; the latest was a $24 million early-stage round in Jun 2023.

PMV mark · valuation
$66.0M
Oct 2026
Priced at
its later-stage round
Jun 2023
Total raised
$41.2M
Last round
Early Stage VC
Jun 2023
How much has Veralox Therapeutics raised?
$41.2Macross 3 recorded rounds · May 2019 – Jun 2023

Most recently, Veralox Therapeutics raised $24.0M in its Early Stage VC (Jun 2023).

Free account
More of Veralox Therapeutics with a free account
  • ·The complete investor list: 15 names
  • ·Watch Veralox Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Veralox Therapeutics round by round

3 rounds
Jun 2023Early Stage VC$24.0MSEC filing▮
14 investors participated
Jun 2021Early Stage VC$14.4MSEC filing▮
17 investors participated
May 2019Debt$1.5MSEC filing▮
6 investors participated

How much has Veralox Therapeutics raised?

Veralox Therapeutics has raised $41.2 million across 3 recorded rounds since 2019. The largest was a $24 million early-stage round in Jun 2023.

Veralox Therapeutics has filed 3 Form Ds with the SEC since 2019, most recently in Jun 2023 ($24 million sold to 14 investors).

Veralox Therapeutics investors

15 investors are on record for Veralox Therapeutics, including Alumni Ventures, Alexandria Venture Investments, TEDCO and NYBC Ventures. The early-stage round in Jun 2023 drew 14 investors.

For fundraisers
Raising for a company like Veralox Therapeutics?

15 investors have backed Veralox Therapeutics.

See all 15 investors →

Frequently asked about Veralox Therapeutics

How much has Veralox Therapeutics raised?
Veralox Therapeutics has raised $41.2M in total across 3 recorded funding rounds.
When was Veralox Therapeutics's last funding round?
Veralox Therapeutics's most recent recorded round was Early Stage VC in Jun 2023, raising $24.0M.